tiprankstipranks

Max N. Wallace Insider Profile

4 Followers
Max N. Wallace, Director at Humacyte, holds 56.55K shares in Humacyte (Ticker: HUMA). Most recently, Max N. Wallace Bought $6,564 shares of Humacyte on Nov 21, 2023 for an estimated value of 7.81K.
tipranks
Max N. Wallace

Max N. Wallace
Humacyte (HUMA)
Director

Not Ranked
Max N. Wallace has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$358K
100.00%
A breakdown of Max N. Wallace's holdings

Insider Roles

Humacyte
(HUMA)
Director
Roles that Max N. Wallace holds in companies

Most Profitable Insider Trade

Stock:
Humacyte
(HUMA)
Rating:Informative Buy
Date:Nov 21, 2023 - Today
Return:+92.60%
The most profitable trade made by Max N. Wallace

Max N. Wallace's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Humacyte
Nov 21, 2023
Director
Informative Buy
7.81K
$357.96K
Success Rate for
HUMA
1 out of 1 profitable transactions on
HUMA
100%
Average Return for
HUMA
Average return per transaction on
HUMA
+92.60%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Nov 21, 2023
Informative Buy
$7.81K
-
$1.19
+92.60%
Aug 27, 2021
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see Max N. Wallace's performance on stock

Max N. Wallace insider profile FAQ

What is the percentage of profitable transactions made by Max N. Wallace?
The percentage of profitable transactions made by Max N. Wallace is ―.
    What is the average return per transaction made by Max N. Wallace?
    The average return per transaction made by Max N. Wallace is ―.
      What stocks does Max N. Wallace hold?
      Max N. Wallace holds: HUMA stocks.
        What was Max N. Wallace’s latest transaction?
        Max N. Wallace latest transaction was an Informative Buy of $7.81K.
          What was Max N. Wallace's most profitable transaction?
          Max N. Wallace’s most profitable transaction was an Informative Buy of HUMA stock on November 21, 2023. The return on the trade was 92.60%.
            What is Max N. Wallace's role in Humacyte?
            Max N. Wallace's role in Humacyte is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.